Home » Article
PCF campaign urges men to ‘Know Your Risk’ for prostate cancer, especially Black men who are more than twice as likely to die from the disease. LOS ANGELES, Calif., February 1, 2023 – This February the Prostate Cancer Foundation (PCF) is teaming up with the Atlanta Hawks for the fifth. Read More
The PCF Challenge Award Winners - Class of 2022 recipients are: 2022 Movember-PCF VAlor Challenge Award Principal Investigators: Isla Garraway, MD, PhD (University of California, Los Angeles; Greater Los Angeles VA Healthcare System), Kara Maxwell, MD, PhD (University of Pennsylvania),Corporal Michael J. Crescenz VA Medical Center), Kosj Yamoah, MD, PhD (Moffit. Read More
LOS ANGELES, Calif., January 31, 2023 – The Prostate Cancer Foundation (PCF) today announced the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million in funding for innovative prostate cancer research. PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly. Read More
En 2020, la FDA aprobó por primera vez un nuevo tipo de estudio llamado PET-TC del PSMA para encontrar el cáncer de próstata en todo el cuerpo. Este estudio más sensible puede detectar metástasis de cáncer de próstata mucho antes, cuando son mucho más pequeñas, y puede mostrar la ubicación. Read More
Have you heard of “Veganuary”? This trend has emerged over the past few years as people aim to eat a plant-based diet for the month of January. While there’s generally no “wrong” time to start making healthier choices, the new year can feel like an opportunity to try new approaches. Read More
Dr. Stacey Kenfield, Associate Professor in the Departments of Urology and Epidemiology & Biostatistics at UCSF, was a guest on PCF’s monthly webinar series hosted by CEO Dr. Charles J. Ryan. She discussed her research on Prostate 8, a collection of lifestyle changes that have been shown to reduce a. Read More
Dear Friends, After completing my first full year leading the Prostate Cancer Foundation (PCF) community of patients, families, researchers, and clinicians, I’m delighted to share with you just how much has happened at PCF in 2022, as we also look ahead to 2023. As you may have seen, we have. Read More
Rising PSA after prostatectomy is common; as many as 40% of patients may experience biochemical recurrence within 10 years. Additional evidence-based guidance is needed about whom to treat, which therapies to use, and how long to treat. The PRESTO trial is collecting data to address this vital question. Results were. Read More
The holidays can bring more complicated cooking adventures and heavier meals than usual. Enjoying leisurely dinners with friends and family is a wonderful way to spend time together. But on your “off” nights, you may want something quick and healthy that you can toss in a pan and be done. Read More
This update on prostate cancer research includes two clinical trials of new therapies presented at the European Society of Medical Oncology (ESMO) Congress 2022, held in Paris. Clinicians, researchers, industry partners, and others from across the globe gathered to share the latest developments in cancer research and treatment. Investigating a. Read More